Contrarian Investing in US Stocks: These ETFs Are Timely Picks

In the current market environment dominated by the “Magnificent Seven”, some investors are starting to explore contrarian opportunities in US stocks. These behemoths—Microsoft (MSFT), Alphabet (GOOGL), Meta (META), Tesla (TSLA), Nvidia (NVDA), Amazon (AMZN), and Apple (AAPL)—while dominating the S&P 500 and Nasdaq-100 indexes, are showing signs of elevated valuations and crowded trades.

The core philosophy of contrarian investing is to “be fearful when others are greedy, and greedy when others are fearful”—buying when the market is generally pessimistic and selling when it is optimistic. The logic behind this investment philosophy is that the market is not entirely efficient; herd mentality often leads to popular sectors being overhyped, creating bubbles, while overlooked sectors are oversold and undervalued. Therefore, based on the theory of mean reversion, contrarian investing in these sectors and stocks can generate excess returns over the long term.

It is also worth mentioning that, compared to contrarian investing in individual stocks, ETFs are an ideal tool for executing this strategy: they mitigate the significant risk of individual “value traps” through diversification, allowing investment in an undervalued sector or strategy in a low-cost and efficient manner, thereby seeking higher potential returns without adding extra risk.

Here are four ETFs currently suitable for contrarian investing in US stocks:

1. Virtus LifeSci Biotech Products ETF (BBP)
   Focuses on holding biotech companies with at least one FDA-approved drug, avoiding the high risks associated with clinical-stage firms. The biotech industry has been under sustained pressure in recent years due to the political environment and funding constraints.
2. Vanguard Value ETF (VTV)
   Tracks the CRSP US Large Cap Value Index, overweighting traditional sectors like financials, healthcare, and industrials, and holding blue-chip stocks such as JPMorgan Chase (JPM) and Berkshire Hathaway (BRK.B). Its annualized return over the past decade is 11.5%, significantly lower than that of growth funds.
3. Distillate Small/Mid Cash Flow ETF (DSMC)
   Screens for quality small- and mid-cap stocks based on free cash flow yield, with a portfolio free cash flow yield of 8.5%, significantly higher than the Russell 2000 Index. Since its inception in October 2022, it has delivered an annualized return of 12.3%.
4. Amplify Natural Resources Dividend Income ETF (NDIV)
   Tracks the EQM Natural Resources Dividend Income Index, investing in resource-related companies such as energy, chemicals, and agriculture, offering a 7.3% SEC yield. In today’s market of stretched valuations, it provides inflation protection and high-income characteristics.

These ETFs offer investors tools to implement contrarian strategies from various angles, including avoiding overvalued tech stocks, focusing on pressured sectors, and emphasizing value and small/mid-cap stocks. Investors can use these products to realize the “buy low, sell high” philosophy of contrarian investing.

Contrarian Investing Funds Oil & Gas Value Stocks